99 related articles for article (PubMed ID: 22796651)
1. A118G Mu Opioid Receptor polymorphism increases inhibitory effects on CaV2.2 channels.
Lopez Soto EJ; Raingo J
Neurosci Lett; 2012 Aug; 523(2):190-4. PubMed ID: 22796651
[TBL] [Abstract][Full Text] [Related]
2. Modulation of Ca2+ channels by heterologously expressed wild-type and mutant human micro-opioid receptors (hMORs) containing the A118G single-nucleotide polymorphism.
Margas W; Zubkoff I; Schuler HG; Janicki PK; Ruiz-Velasco V
J Neurophysiol; 2007 Feb; 97(2):1058-67. PubMed ID: 17151221
[TBL] [Abstract][Full Text] [Related]
3. Differential sensitivity of N- and P/Q-type Ca2+ channel currents to a mu opioid in isolectin B4-positive and -negative dorsal root ganglion neurons.
Wu ZZ; Chen SR; Pan HL
J Pharmacol Exp Ther; 2004 Dec; 311(3):939-47. PubMed ID: 15280436
[TBL] [Abstract][Full Text] [Related]
4. Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor.
Beyer A; Koch T; Schröder H; Schulz S; Höllt V
J Neurochem; 2004 May; 89(3):553-60. PubMed ID: 15086512
[TBL] [Abstract][Full Text] [Related]
5. Analgesic tolerance of opioid agonists in mutant mu-opioid receptors expressed in sensory neurons following intrathecal plasmid gene delivery.
Li G; Ma F; Gu Y; Huang LY
Mol Pain; 2013 Dec; 9():63. PubMed ID: 24304623
[TBL] [Abstract][Full Text] [Related]
6. The N-terminally truncated µ3 and µ3-like opioid receptors are transcribed from a novel promoter upstream of exon 2 in the human OPRM1 gene.
Andersen S; Baar C; Fladvad T; Laugsand EA; Skorpen F
PLoS One; 2013; 8(8):e71024. PubMed ID: 23951073
[TBL] [Abstract][Full Text] [Related]
7. Functional compartmentalization of opioid desensitization in primary sensory neurons.
Samoriski GM; Gross RA
J Pharmacol Exp Ther; 2000 Aug; 294(2):500-9. PubMed ID: 10900225
[TBL] [Abstract][Full Text] [Related]
8. Opioidergic modulation of excitability of rat trigeminal root ganglion neuron projections to the superficial layer of cervical dorsal horn.
Takeda M; Tanimoto T; Ikeda M; Kadoi J; Nasu M; Matsumoto S
Neuroscience; 2004; 125(4):995-1008. PubMed ID: 15120859
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of Cav2.2 channel exon 37 variants by alternatively spliced μ-opioid receptors.
Gandini MA; Souza IA; Raval D; Xu J; Pan YX; Zamponi GW
Mol Brain; 2019 Nov; 12(1):98. PubMed ID: 31775826
[TBL] [Abstract][Full Text] [Related]
10. Mouse model of OPRM1 (A118G) polymorphism has altered hippocampal function.
Mague SD; Port RG; McMullen ME; Carlson GC; Turner JR
Neuropharmacology; 2015 Oct; 97():426-35. PubMed ID: 25986698
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
Hammond DL; Wang H; Nakashima N; Basbaum AI
J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201
[TBL] [Abstract][Full Text] [Related]
12. The mu opioid receptor modulates neurotransmission in the rat spinal ventral horn.
Honda H; Kawasaki Y; Baba H; Kohno T
Anesth Analg; 2012 Sep; 115(3):703-12. PubMed ID: 22584545
[TBL] [Abstract][Full Text] [Related]
13. Opioid peptide receptor studies. 16. Chronic morphine alters G-protein function in cells expressing the cloned mu opioid receptor.
Xu H; Lu YF; Rothman RB
Synapse; 2003 Jan; 47(1):1-9. PubMed ID: 12422367
[TBL] [Abstract][Full Text] [Related]
14. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
15. Agonist binding of human mu opioid receptors expressed in the yeast Pichia pastoris: Effect of cholesterol complementation.
Talmont F; Lebrun C; Zajac JM
Neurochem Int; 2020 Jan; 132():104588. PubMed ID: 31704091
[TBL] [Abstract][Full Text] [Related]
16. Activation of mu-opioid receptor selectively potentiates NMDA-induced outward currents in rat locus coeruleus neurons.
Koyama S; Akaike N
Neurosci Res; 2008 Jan; 60(1):22-8. PubMed ID: 17976846
[TBL] [Abstract][Full Text] [Related]
17. A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling.
Befort K; Filliol D; Decaillot FM; Gaveriaux-Ruff C; Hoehe MR; Kieffer BL
J Biol Chem; 2001 Feb; 276(5):3130-7. PubMed ID: 11067846
[TBL] [Abstract][Full Text] [Related]
18. Sustained inhibition of neurotransmitter release from nontransient receptor potential vanilloid type 1-expressing primary afferents by mu-opioid receptor activation-enkephalin in the spinal cord.
Zhou HY; Chen SR; Chen H; Pan HL
J Pharmacol Exp Ther; 2008 Nov; 327(2):375-82. PubMed ID: 18669865
[TBL] [Abstract][Full Text] [Related]
19. Expression of mu opioid receptor splice variants mRNA in human blood lymphocytes: a peripheral marker for opioid addiction studies.
Vousooghi N; Goodarzi A; Roushanzamir F; Sedaghati T; Zarrindast MR; Noori-Daloii MR
Int Immunopharmacol; 2009 Jul; 9(7-8):1016-20. PubMed ID: 19272466
[TBL] [Abstract][Full Text] [Related]
20. Functional mu opioid receptors are expressed in cholinergic interneurons of the rat dorsal striatum: territorial specificity and diurnal variation.
Jabourian M; Venance L; Bourgoin S; Ozon S; Pérez S; Godeheu G; Glowinski J; Kemel ML
Eur J Neurosci; 2005 Jun; 21(12):3301-9. PubMed ID: 16026468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
